tacrolimus and baricitinib

tacrolimus has been researched along with baricitinib* in 2 studies

Reviews

1 review(s) available for tacrolimus and baricitinib

Article	Year
Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus. Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5 Topics: Adult; Alopecia; Azetidines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase Inhibitors; Lupus Erythematosus, Systemic; Mycophenolic Acid; Prednisolone; Purines; Pyrazoles; Retreatment; Risk Assessment; Sulfonamides; Tacrolimus; Treatment Outcome	2020

Article

Year

Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus.

Annals of the rheumatic diseases, 2020, Volume: 79, Issue:5

Topics: Adult; Alopecia; Azetidines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase Inhibitors; Lupus Erythematosus, Systemic; Mycophenolic Acid; Prednisolone; Purines; Pyrazoles; Retreatment; Risk Assessment; Sulfonamides; Tacrolimus; Treatment Outcome

2020

Other Studies

1 other study(ies) available for tacrolimus and baricitinib

Article	Year
Cytomegalovirus Enteritis Induced by Baricitinib and Tacrolimus: Association or Coincidence? The Journal of rheumatology, 2022, Volume: 49, Issue:4 Topics: Antirheumatic Agents; Azetidines; Cytomegalovirus; Enteritis; Humans; Methotrexate; Purines; Pyrazoles; Sulfonamides; Tacrolimus; Treatment Outcome	2022